CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,602 | -99.7% | 274,282 | +213.9% | 0.00% | – |
| Q3 2022 | $585,000 | +200.0% | 87,367 | +88.5% | 0.00% | – |
| Q2 2022 | $195,000 | – | 46,349 | +110254.8% | 0.00% | – |
| Q1 2022 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 42 | -98.2% | 0.00% | – |
| Q3 2021 | $8,000 | -94.9% | 2,304 | -93.8% | 0.00% | – |
| Q2 2021 | $157,000 | -80.1% | 37,184 | -76.4% | 0.00% | – |
| Q1 2021 | $787,000 | -60.4% | 157,770 | +0.5% | 0.00% | – |
| Q4 2020 | $1,985,000 | +90.1% | 157,018 | +45.2% | 0.00% | – |
| Q3 2020 | $1,044,000 | -8.8% | 108,143 | -6.0% | 0.00% | – |
| Q2 2020 | $1,145,000 | -1.5% | 115,082 | -12.6% | 0.00% | – |
| Q1 2020 | $1,163,000 | -25.0% | 131,717 | -21.6% | 0.00% | – |
| Q4 2019 | $1,550,000 | +69.4% | 167,954 | +7.9% | 0.00% | – |
| Q3 2019 | $915,000 | -48.2% | 155,637 | +3.4% | 0.00% | – |
| Q2 2019 | $1,768,000 | -1.3% | 150,592 | +1.4% | 0.00% | – |
| Q1 2019 | $1,792,000 | -4.2% | 148,495 | -0.4% | 0.00% | – |
| Q4 2018 | $1,871,000 | -32.5% | 149,138 | -20.2% | 0.00% | -100.0% |
| Q3 2018 | $2,773,000 | +8.4% | 186,831 | +23.0% | 0.00% | 0.0% |
| Q2 2018 | $2,557,000 | -23.8% | 151,911 | +3.7% | 0.00% | 0.0% |
| Q1 2018 | $3,355,000 | -18.0% | 146,508 | -7.3% | 0.00% | 0.0% |
| Q4 2017 | $4,089,000 | +9409.3% | 158,066 | +5000.5% | 0.00% | – |
| Q2 2017 | $43,000 | -95.2% | 3,099 | -94.1% | 0.00% | – |
| Q1 2017 | $900,000 | +111.3% | 52,783 | +27.5% | 0.00% | – |
| Q4 2016 | $426,000 | +317.6% | 41,391 | +311.0% | 0.00% | – |
| Q3 2016 | $102,000 | +10100.0% | 10,070 | +28671.4% | 0.00% | – |
| Q4 2015 | $1,000 | -99.8% | 35 | -99.9% | 0.00% | – |
| Q3 2015 | $564,000 | -81.6% | 30,035 | -86.8% | 0.00% | -100.0% |
| Q1 2014 | $3,057,000 | – | 227,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |